Management of Post-Stroke Numbness and Tingling
For right foot and arm numbness and tingling years after stroke, initiate amitriptyline 75 mg at bedtime as first-line pharmacotherapy for central poststroke pain, combined with interprofessional pain management and therapeutic exercise. 1
Diagnostic Confirmation
First, confirm this is central poststroke pain (CPSP) rather than other causes:
- Verify the symptoms correspond anatomically to the original stroke lesion location - the numbness/tingling should map to the affected brain territory 1
- Rule out peripheral neuropathic causes - check for diabetes, peripheral nerve compression, cervical radiculopathy, or musculoskeletal trigger points 2, 3
- Apply established diagnostic criteria for CPSP: pain/sensory abnormalities in body regions corresponding to the CNS lesion, not explained by nociceptive or peripheral mechanisms 1
- CPSP typically presents as burning or aching sensations with allodynia (pain from normally non-painful stimuli like touch, cold, or movement) 1
Pharmacological Management Algorithm
First-Line Treatment:
- Amitriptyline 75 mg at bedtime - demonstrated to lower daily pain ratings and improve global functioning 1
- Alternative first-line: Lamotrigine - reduces daily pain and cold-induced pain, though only 44% achieve good clinical response 1
Second-Line Options (if first-line fails or not tolerated):
- Pregabalin - mixed evidence for pain reduction but improves sleep and anxiety 1
- Gabapentin - not well-studied for poststroke pain specifically but effective in other neuropathic pain 1
- Carbamazepine or phenytoin - usefulness not well established 1
Treatment Monitoring:
- Use standardized serial measurements: pain diaries, visual analog scales, or validated pain questionnaires 1
- Individualize medication choice based on patient response, side effects, and comorbidities 1
Non-Pharmacological Interventions
Interprofessional pain management is recommended in conjunction with medications 1:
- Therapeutic exercise programs
- Psychosocial support
- Physical therapy for functional optimization
Avoid TENS (transcutaneous electrical nerve stimulation) - shown to be ineffective in trials 1
Refractory Cases
For intractable CPSP unresponsive to pharmacotherapy:
- Motor cortex stimulation may be considered in carefully selected patients - achieves >50% pain reduction in 50-83% of cases, but carries risks of infection, hardware failure, seizures, and long-term epilepsy 1
- Deep brain stimulation is NOT recommended - conflicting evidence, not established as effective 1
Comprehensive Post-Stroke Care Context
Beyond pain management, ensure ongoing primary care includes 4:
- Screen for common complications: depression (adversely affects recovery), cognitive impairment, fall risk
- Secondary stroke prevention: blood pressure control, atrial fibrillation management, diabetes control, lipid management
- Functional assessment: refer to rehabilitation services if ongoing impairments exist
Critical Pitfalls to Avoid
- Don't assume all post-stroke sensory symptoms are CPSP - peripheral causes are common and treatable differently
- Don't delay treatment - CPSP typically begins within days to first month post-stroke, but can present later 1
- Don't use monotherapy alone - combination of pharmacotherapy with interprofessional pain management yields better outcomes 1
- Don't forget bone health - stroke patients have accelerated bone mineral density loss and higher fracture risk 1